About Sêmeia
Sêmeia is a company founded in 2017 by Daniel Szeftel and Pierre Hornus. It operates as a SaaS (Software-as-a-Service), and HealthTech. Sêmeia has raised $8.39 million across 1 funding round from investors including Banque des Territoires, Orange Ventures and Malakoff Humanis. Sêmeia offers products and services including NephroWise, MentalWise, OncoWise, CardioWise, and PneumoWise. Sêmeia operates in a competitive market with competitors including Vivify Health, Somatix, PhysIQ, Flashback Technologies and Doctomatic, among others.
- Founders Daniel Szeftel, Pierre Hornus
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$8.39 M (USD)
in 1 rounds
-
Latest Funding Round
$8.39 M (USD), Series A
Dec 08, 2022
-
Investors
Banque des Territoires
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sêmeia
Sêmeia offers a comprehensive portfolio of products and services, including NephroWise, MentalWise, OncoWise, CardioWise, and PneumoWise. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Patient monitoring for kidney transplant and insufficiency cases.
Mental health tracking for bipolar and depression patients.
Oncology patient follow-up for breast and prostate cancer.
Cardiac care monitoring for heart failure and diabetes.
Respiratory monitoring for asthma and sleep apnea patients.
Rheumatology tracking for patients with rheumatoid arthritis issues.
Funding Insights of Sêmeia
Sêmeia has successfully raised a total of $8.39M through 1 strategic funding round. The most recent funding activity was a Series A round of $8.39 million completed in December 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $8.4M
-
First Round
First Round
(08 Dec 2022)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2022 | Amount | Series A - Sêmeia | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Sêmeia
Sêmeia has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Banque des Territoires, Orange Ventures and Malakoff Humanis. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are directed toward startups and early-stage companies.
|
Founded Year | Domain | Location | |
|
Offers insurance, savings, and retirement services for individuals, enterprises, and independents.
|
Founded Year | Domain | Location | |
|
Legal and finance advisory services are provided to clients.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Sêmeia
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Sêmeia
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sêmeia Comparisons
Competitors of Sêmeia
Sêmeia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Vivify Health, Somatix, PhysIQ, Flashback Technologies and Doctomatic, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cloud-based platform for remote patient monitoring and engagement is delivered.
|
|
| domain | founded_year | HQ Location |
AI-based remote health monitoring tools are provided for patient care.
|
|
| domain | founded_year | HQ Location |
Personalized physiology data analytics are delivered via an AI platform.
|
|
| domain | founded_year | HQ Location |
AI-based decision support is provided for professionals in critical care.
|
|
| domain | founded_year | HQ Location |
AI-based healthcare monitoring is provided for providers and patients.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Sêmeia
When was Sêmeia founded?
Sêmeia was founded in 2017 and raised its 1st funding round 5 years after it was founded.
Who is the current CEO of Sêmeia?
Pierre Hornus is the current CEO of Sêmeia. They have also founded this company.
Is Sêmeia a funded company?
Sêmeia is a funded company, having raised a total of $8.39M across 1 funding round to date. The company's 1st funding round was a Series A of $8.39M, raised on Dec 08, 2022.
What does Sêmeia do?
Sêmeia is engaged in providing telemonitoring solutions for patients with chronic conditions. Various sectors such as nephrology, oncology, mental health, cardiology, pneumology, and rheumatology are covered by their specialized products. Data security and AI-driven risk prediction are integrated to enhance personalized care plans. Patient data is managed securely with direct communication tools like chat and teleconsultation. The solutions are designed to improve care quality and reduce hospitalizations by enabling timely medical interventions.
Who are the top competitors of Sêmeia?
Sêmeia's top competitors include Vivify Health, Somatix and PhysIQ.
What products or services does Sêmeia offer?
Sêmeia offers NephroWise, MentalWise, OncoWise, CardioWise, and 2 more products and services.
Who are Sêmeia's investors?
Sêmeia has 3 investors. Key investors include Banque des Territoires, Orange Ventures, and Malakoff Humanis.